Hemophilia

Hemophilia


​FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.  

Data Elements


DEMOGRAPHICS

  • Diagnosis
  • Age
  • Gender
  • Race / Ethnicity
  • BMI
  • Height / Weight

PT CHARACTERISTICS

  • Hemophilia Severity
  • IV Access Method
  • Target Joints
  • Prophylaxis vs. Breakthrough Bleeding Products
  • Inhibitor Use
  • Last Bleed Date
  • Number of Bleeds

PRIOR HISTORY

  • First Diagnosis of Hemophilia Date
  • Prior Regimen
  • Prior Treatment Status (new to therapy or refill)
  • Duration of Therapy
  • Reason for Switch

PT ADHERENCE

  • Current Therapy
  • Duration
  • Dose
  • Prophylaxis Product Use
  • Bleeding Product Use
  • % Doses Taken
  • % Doses Missed

PROVIDERS

  • Type (Physician, NP, PA)
  • Specialty
  • Academic vs Community
  • Specialty Pharmacy vs. Hemophilia Treatment Center

PAYERS

  • Type (Commercial, Medicare, Medicaid, Dual Eligible)
  • Payer Name
  • Self-Pay and Patient Assistance
  • Eligibility
  • Correct PA form
  • Denial Reason

PA TIMELINE

  • Copay Amount
  • PA Submitted Date
  • Approval / Denial Date
  • Appeals Submitted

DISPENSING INFO

  • Current Treatment Regimen Rx
  • Intended Regimen
  • Actual Regimen
  • Duration
  • Dispensed Regimen
  • Duration / Refills
  • Gaps in Therapy

Patient Tear Sheet


Real Time Aggregated Data is organized and visualized at a patient level for immediate and longitudinal insight.
Click on image below for a 3 page PDF of a Patient Tear Sheet.

Publications


2018


A Retrospective, Observational Study of BAX 855 in Clinical Practice in the United States

J. Booth, M. Watt, S. Milligan, L. Aledort

Poster Presented at: Academy of Managed Care Pharmacy (AMCP)

Conference dates: April 23, 2018 - April 26, 2018